Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
British Journal of Cancer
|
May 2, 2013
Are the UK oncology trainees adequately informed about the needs of older people with cancer?
T Kalsi, S Payne, H Brodie, et al.
Journal of Clinical Pathology
|
August 1, 1992
Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma
J B Schofield, J Mansi, R S Camplejohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1992
High-dose busulfan in patients with myeloma
J Mansi, F da Costa, C Viner, et al.
Magma (New York, N.Y.)
|
February 11, 2005
The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods
L M Rodrigues, M Stubbs, S P Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
R Leonard, J Hardy, G van Tienhoven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2017
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer
R A Anderson, J Mansi, R E Coleman, et al.
International Journal of Laboratory Hematology
|
July 10, 2007
Guidelines on the insertion and management of central venous access devices in adults
L Bishop, L Dougherty, A Bodenham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma
M Hill, D Cunningham, D MacVicar, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling
J Mansi, E Ellis, C Viner, et al.
British Dental Journal
|
December 16, 2017
MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
V Patel, J Mansi, S Ghosh, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
British Journal of Cancer
|
May 2, 2013
Are the UK oncology trainees adequately informed about the needs of older people with cancer?
T Kalsi, S Payne, H Brodie, et al.
Journal of Clinical Pathology
|
August 1, 1992
Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma
J B Schofield, J Mansi, R S Camplejohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1992
High-dose busulfan in patients with myeloma
J Mansi, F da Costa, C Viner, et al.
Magma (New York, N.Y.)
|
February 11, 2005
The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods
L M Rodrigues, M Stubbs, S P Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
R Leonard, J Hardy, G van Tienhoven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2017
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer
R A Anderson, J Mansi, R E Coleman, et al.
International Journal of Laboratory Hematology
|
July 10, 2007
Guidelines on the insertion and management of central venous access devices in adults
L Bishop, L Dougherty, A Bodenham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma
M Hill, D Cunningham, D MacVicar, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling
J Mansi, E Ellis, C Viner, et al.
British Dental Journal
|
December 16, 2017
MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
V Patel, J Mansi, S Ghosh, et al.
Page
of 4